During the past decade, Matsuda Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matsuda Hospital" #1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Matsuda Hospital" are "Colitis, Ulcerative" (2 trials), "Crohn's Disease" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Matsuda Hospital" in a lesser frequency.

Most popular intervention types in "Matsuda Hospital" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials), "Guselkumab Dose 3" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Matsuda Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Matsuda Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Matsuda Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Matsuda Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".